Terms: = Germ cell tumor AND FANCE, 2178, ENSG00000112039, FAE
14 results:
1. MRI characteristics of H3 G34-mutant diffuse hemispheric gliomas and possible differentiation from IDH-wild-type glioblastomas in adolescents and young adults.
Shao H; Gong J; Su X; Chen N; Li S; Yang X; Zhang S; Huang Z; Hu W; Gong Q; Liu Y; Yue Q
J Neurosurg Pediatr; 2024 Mar; 33(3):236-244. PubMed ID: 38157540
[TBL] [Abstract] [Full Text] [Related]
2. Awake craniotomy for high-grade gliomas - a prospective cohort study in a UK tertiary-centre.
Ramakrishnan PK; Saeed F; Thomson S; Corns R; Mathew RK; Sivakumar G
Surgeon; 2024 Feb; 22(1):e3-e12. PubMed ID: 38008681
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine tumors with Liver Metastases.
Tsang ES; Loree JM; Davies JM; Gill S; Liu D; Ho S; Renouf DJ; Lim HJ; Kennecke HF
Can J Gastroenterol Hepatol; 2020; 2020():5104082. PubMed ID: 33299824
[TBL] [Abstract] [Full Text] [Related]
4. germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas.
Chan SH; Lim WK; Ishak NDB; Li ST; Goh WL; Tan GS; Lim KH; Teo M; Young CNC; Malik S; Tan MH; Teh JYH; Chin FKC; Kesavan S; Selvarajan S; Tan P; Teh BT; Soo KC; Farid M; Quek R; Ngeow J
Sci Rep; 2017 Sep; 7(1):10660. PubMed ID: 28878254
[TBL] [Abstract] [Full Text] [Related]
5. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
[TBL] [Abstract] [Full Text] [Related]
6. Forsythiae Fructus Inhibits B16 Melanoma Growth Involving MAPKs/Nrf2/HO-1 Mediated Anti-Oxidation and Anti-Inflammation.
Bao J; Ding R; Zou L; Zhang C; Wang K; Liu F; Li P; Chen M; Wan JB; Su H; Wang Y; He C
Am J Chin Med; 2016; 44(5):1043-61. PubMed ID: 27430915
[TBL] [Abstract] [Full Text] [Related]
7. An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection.
Foote M; Burmeister B; Dwyer P; Burmeister E; Lambie D; Allan C; Barbour A; Bayley G; Pullar A; Meakin J; Thomas J; Smithers M
Melanoma Res; 2012 Jun; 22(3):257-62. PubMed ID: 22547205
[TBL] [Abstract] [Full Text] [Related]
8. Intralabyrinthine schwannomas: imaging diagnosis and classification.
Salzman KL; Childs AM; Davidson HC; Kennedy RJ; Shelton C; Harnsberger HR
AJNR Am J Neuroradiol; 2012 Jan; 33(1):104-9. PubMed ID: 22158921
[TBL] [Abstract] [Full Text] [Related]
9. Malignant melanoma during treatment with fumaric acid esters - coincidence or treatment-related?
Barth D; Simon JC; Wetzig T
J Dtsch Dermatol Ges; 2011 Mar; 9(3):223-5. PubMed ID: 20678147
[TBL] [Abstract] [Full Text] [Related]
10. A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas.
Raizer JJ; Grimm S; Chamberlain MC; Nicholas MK; Chandler JP; Muro K; Dubner S; Rademaker AW; Renfrow J; Bredel M
Cancer; 2010 Nov; 116(22):5297-305. PubMed ID: 20665891
[TBL] [Abstract] [Full Text] [Related]
11. Carotid chemodectomas: long-term results of subadventitial resection with deliberate external carotid resection.
Koskas F; Vignes S; Khalil I; Koskas I; Dziekiewicz M; Elmkies F; Lamas G; Kieffer E
Ann Vasc Surg; 2009; 23(1):67-75. PubMed ID: 18815007
[TBL] [Abstract] [Full Text] [Related]
12. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
Terezakis SA; Lee KS; Ghossein RA; Rivera M; Tuttle RM; Wolden SL; Zelefsky MJ; Wong RJ; Patel SG; Pfister DG; Shaha AR; Lee NY
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):795-801. PubMed ID: 18676097
[TBL] [Abstract] [Full Text] [Related]
13. Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas.
Baldelli R; Bianchi A; Diacono F; Passeri M; Fusco A; Valle D; Poggi M; Terlini M; Toscano V; Tamburrano G; Pontecorvi A; Maira G; De Marinis L
J Endocrinol Invest; 2005 Feb; 28(2):157-61. PubMed ID: 15887862
[TBL] [Abstract] [Full Text] [Related]
14. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.
Sneed PK; Stauffer PR; McDermott MW; Diederich CJ; Lamborn KR; Prados MD; Chang S; Weaver KA; Spry L; Malec MK; Lamb SA; Voss B; Davis RL; Wara WM; Larson DA; Phillips TL; Gutin PH
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):287-95. PubMed ID: 9457811
[TBL] [Abstract] [Full Text] [Related]
